Enovis, the medical technology company, just completed the sale of its Dr. Comfort diabetic footwear segment to Promus Equity Partners. This strategic move is intended to sharpen Enovis’ focus on its ...
What Happened? Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 3.3% in the afternoon session after ...
This transaction represents a positive outcome for Enovis, our Dr. Comfort business, and Promus Equity Partners,” said Damien McDonald, Enovis’ Chief Executive Officer. “The sale sharpens our focus on ...
Enovis (ENOV) announced the sale of its Dr. Comfort diabetic shoe business to Promus Equity Partners, a multi-family asset management firm based ...